Inge Vrelust
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Mast cells and histamine
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Alain Gadisseur (7 shared papers)Didier Gaston Ebo (1 shared paper)Geert R. Mortier (1 shared paper)Peter Valent (1 shared paper)Luc S. De Clerck (1 shared paper)Erik Fransén (1 shared paper)Els Van de Vijver (1 shared paper)Vito Sabato (1 shared paper)
- Journals
- Blood (4 papers)Thrombosis and Haemostasis (1 paper)Annals of Hematology (1 paper)HemaSphere (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- BelgiumJapanUnited Kingdom
In The Last Decade
Inge Vrelust
17 papers receiving 457 citations
Peers
Comparison fields: 5 of 33
- Immunology 284
- Hematology 119
- Oncology 41
- Microbiology 1
- Toxicology 5
Countries citing papers authored by Inge Vrelust
This map shows the geographic impact of Inge Vrelust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Vrelust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Vrelust more than expected).
Fields of papers citing papers by Inge Vrelust
This network shows the impact of papers produced by Inge Vrelust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Vrelust. The network helps show where Inge Vrelust may publish in the future.
Co-authors
The 25 scholars most cited alongside Inge Vrelust, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 327 | |
| 2 | 2014 | 43 | |
| 3 | 2021 | 19 | |
| 4 | 2010 | 9 | |
| 5 | 2017 | 9 | |
| 6 | 2014 | 8 | |
| 7 | 2014 | 8 | |
| 8 | 2013 | 7 | |
| 9 | 2012 | 6 | |
| 10 | 2010 | 5 | |
| 11 | 2011 | 5 | |
| 12 | 2012 | 4 | |
| 13 | 2022 | 3 | |
| 14 | 2025 | 3 | |
| 15 | 2007 | 2 | |
| 16 | 2008 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Inge Vrelust
Inge Vrelust is a scholar working on Hematology, Immunology, Microbiology, Toxicology and Pathology and Forensic Medicine, having authored 19 papers that have together received 461 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Autoimmune and Inflammatory Disorders (1 paper), Antifungal resistance and susceptibility (1 paper), Retinoids in leukemia and cellular processes (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Cancer survivorship and care (1 paper). The work is most often cited by research in Immunology (284 citations), Hematology (119 citations), Oncology (41 citations), Microbiology (1 citation) and Toxicology (5 citations). Inge Vrelust has collaborated with scholars based in Belgium, Japan and United Kingdom. Frequent co-authors include Alain Gadisseur, Didier Gaston Ebo, Geert R. Mortier, Peter Valent, Luc S. De Clerck, Erik Fransén, Els Van de Vijver, Vito Sabato, Margo Maria Hagendorens and Chris H. Bridts. Their work appears in journals such as Blood, Thrombosis and Haemostasis, Annals of Hematology, HemaSphere and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.